Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Post-Approval Study of MelaFind

This study has been terminated.
(FDA withdrew requirement to complete study)
Information provided by (Responsible Party):
MELA Sciences, Inc. Identifier:
First received: October 2, 2012
Last updated: March 10, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)